Logo
e

eXmoor Pharma

78 employees

eXmoor Pharma is more than a CDMO—we are your expert partner in cell and gene therapy development. As the only integrated CGT CDMO with embedded consultancy expertise, we support clients at every stage of their journey, from early-phase strategy to GMP manufacturing and commercialisation. For over 20 years, we have provided specialised CMC consulting, process development, and GMP clinical manufacturing to more than 170 clients. Our industry-leading scientists and strategists help biotech and pharma companies accelerate innovation while reducing risk and costs. Our purpose-built process development and GMP manufacturing facility offers end-to-end solutions across Viral Vectors, Autologous & Allogeneic Cell Therapies, and RNA Technologies. Unlike traditional CDMOs, we offer flexibility, full transparency, and IP freedom, ensuring you remain in control of your therapy’s future. Trusted by Industry Leaders Long-term partnerships define our success—70% of our clients return for ongoing collaboration. From academic innovators to biotech spin-outs and global pharma companies, we provide the expertise, infrastructure, and strategic foresight to transform groundbreaking science into life-changing therapies. Our Culture: Collaboration, Innovation, and Impact Much like our client relationships, our work culture is built on capability, collaboration, and trust. We create an environment where expertise thrives, encouraging innovation, continuous learning, and cross-functional teamwork. Our team works side by side, sharing knowledge and insights to drive the future of cell and gene therapy. Rooted in transparency, problem-solving, and scientific excellence, our culture empowers people to grow, lead, and make a meaningful impact in an evolving industry. To learn more about eXmoor Pharma, visit our website: www.exmoorpharma.com and to join our team visit: www.exmoorpharma.com/careers

Investor insights

Funding rounds participated in

$35M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2004

Funding rounds raised

Total raised

$35M

from 1 investors over 1 rounds

e

eXmoor Pharma raised $35M on June 30, 2023

Investors: Kineticos Ventures

FAQ